SEC 13F Intelligence

Capital International Investors / EW

Capital International Investors’s Edwards Lifesciences Corp Position

Does Capital International Investors own Edwards Lifesciences Corp (EW)? Not currently — the last reported position was 2.12M shares worth $140M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$140M
Q3 2024
Shares
2.12M
% of Portfolio
+0.03%
Quarters Held
22
position exited

Position History EW

Reported value by quarter
Q2 ’19: $518MQ2 ’19Q3 ’19: $830MQ4 ’19: $1.0BQ1 ’20: $974MQ1 ’20Q2 ’20: $1.1BQ3 ’20: $1.4BQ4 ’20: $1.6BQ4 ’20Q1 ’21: $1.6BQ2 ’21: $2.1BQ3 ’21: $2.3BQ3 ’21Q4 ’21: $2.8BQ1 ’22: $2.6BQ2 ’22: $2.1BQ2 ’22Q3 ’22: $1.9BQ4 ’22: $1.7BQ1 ’23: $2.1BQ1 ’23Q2 ’23: $2.5BQ3 ’23: $2.1BQ4 ’23: $690MQ4 ’23Q1 ’24: $212MQ2 ’24: $194MQ3 ’24: $140MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20242.12M$140M+0.03%
Q2 20242.10M$194M+0.04%
Q1 20242.22M$212M+0.04%
Q4 20239.04M$690M+0.15%
Q3 202330.25M$2.1B+0.53%
Q2 202327.02M$2.5B+0.61%
Q1 202325.76M$2.1B+0.55%
Q4 202222.74M$1.7B+0.46%
Q3 202222.70M$1.9B+0.55%
Q2 202222.40M$2.1B+0.58%
Q1 202222.15M$2.6B+0.59%
Q4 202121.93M$2.8B+0.60%
Q3 202120.68M$2.3B+0.54%
Q2 202120.00M$2.1B+0.47%
Q1 202118.89M$1.6B+0.40%
Q4 202017.85M$1.6B+0.44%
Q3 202017.48M$1.4B+0.43%
Q2 202016.26M$1.1B+0.37%
Q1 20205.17M$974M+0.40%
Q4 20194.46M$1.0B+0.35%
Q3 20193.78M$830M+0.32%
Q2 20192.80M$518M+0.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capital International Investors’s full portfolio or all institutional holders of EW.